Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hemangioma, Capillary × Nadolol × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma, Capillary 1

Interventions

Imiquimod 2 Timolol 1 Ointments 1 Nadolol 1 Mupirocin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01010308 2021-08-19

Nadolol for Proliferating Infantile Hemangiomas

The Hospital for Sick Children

Phase 2 Completed

Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡